Heikki Seikkula

475 total citations
30 papers, 204 citations indexed

About

Heikki Seikkula is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Heikki Seikkula has authored 30 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Heikki Seikkula's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Heikki Seikkula is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Heikki Seikkula collaborates with scholars based in Finland, United States and Australia. Heikki Seikkula's co-authors include Peter J. Boström, Tuomas Mirtti, Pekka Taimen, Antti Kaipia, Janne Pitkäniemi, Nea Malila, Andrew Erickson, Antti Rannikko, Hanna Vasarainen and Stig Nordling and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Heikki Seikkula

26 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heikki Seikkula Finland	8	104	79	51	33	28	30	204
R.G.H.M. Cremers Netherlands	8	142 1.4×	35 0.4×	43 0.8×	28 0.8×	37 1.3×	16	222
Shivanshu Awasthi United States	10	231 2.2×	79 1.0×	142 2.8×	28 0.8×	91 3.3×	27	353
Stephen Zappala United States	10	191 1.8×	31 0.4×	27 0.5×	37 1.1×	53 1.9×	21	239
Marguerite du Plessis United States	7	199 1.9×	46 0.6×	63 1.2×	80 2.4×	65 2.3×	22	290
Yuchao Ni China	8	118 1.1×	44 0.6×	40 0.8×	26 0.8×	42 1.5×	26	176
Jindong Dai China	9	117 1.1×	58 0.7×	44 0.9×	29 0.9×	55 2.0×	35	191
Haowen Jiang China	12	220 2.1×	55 0.7×	92 1.8×	29 0.9×	57 2.0×	20	303
Elizabeth Liow Australia	10	116 1.1×	66 0.8×	131 2.6×	80 2.4×	46 1.6×	26	235
Johan Bondi Norway	9	41 0.4×	92 1.2×	159 3.1×	83 2.5×	41 1.5×	14	279
Natalie Q. Wang Canada	2	111 1.1×	24 0.3×	53 1.0×	79 2.4×	28 1.0×	2	172

Countries citing papers authored by Heikki Seikkula

Since Specialization

Citations

This map shows the geographic impact of Heikki Seikkula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heikki Seikkula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heikki Seikkula more than expected).

Fields of papers citing papers by Heikki Seikkula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heikki Seikkula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heikki Seikkula. The network helps show where Heikki Seikkula may publish in the future.

Co-authorship network of co-authors of Heikki Seikkula

This figure shows the co-authorship network connecting the top 25 collaborators of Heikki Seikkula. A scholar is included among the top collaborators of Heikki Seikkula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heikki Seikkula. Heikki Seikkula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahtiainen, Juha P., Eija K. Laakkonen, Pirjo Käkelä, et al.. (2025). Testosterone levels at diagnosis: A key predictor of overall survival among patients with prostate cancer. BJUI Compass. 6(2). e484–e484.

Salminen, Antti, et al.. (2025). Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: A Nationwide Analysis of Eligibility, Utilization, and Outcomes. Cancers. 17(3). 505–505.

Ahtiainen, Juha P., Eija K. Laakkonen, Aino Siltari, et al.. (2024). Transdermal oestradiol and exercise in androgen deprivation therapy ( ESTRACISE ): protocol. British Journal of Urology. 134(1). 110–118. 1 indexed citations

Helminen, Olli, et al.. (2024). CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma. Acta Oncologica. 63. 105–110. 2 indexed citations

Seikkula, Heikki, et al.. (2024). The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy. SHILAP Revista de lepidopterología. 5(11). 1220–1227. 1 indexed citations

Salminen, Antti, Heikki Seikkula, Ileana Montoya Perez, et al.. (2023). Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland. Acta Oncologica. 62(8). 829–835. 2 indexed citations

Seikkula, Heikki, et al.. (2023). Optimal Strategies for Managing Prostate-specific Antigen Recurrence After Primary Radiotherapy in Prostate Cancer: The Finnish Perspective. European Urology Focus. 9(5). 698–700. 1 indexed citations

Yu, Lan, Mervi Toriseva, Vidal Fey, et al.. (2022). Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression. Cancers. 14(2). 278–278. 5 indexed citations

Seikkula, Heikki, Antti Kaipia, Peter J. Boström, et al.. (2022). Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019. Acta Oncologica. 61(10). 1209–1215. 3 indexed citations

10.

Seikkula, Heikki, Peter J. Boström, Karri Seppä, et al.. (2020). Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation. BMC Urology. 20(1). 1 indexed citations

11.

Seikkula, Heikki, et al.. (2020). Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland. Cancer Epidemiology. 69. 101807–101807. 2 indexed citations

12.

Seikkula, Heikki, Antti Kaipia, Matti Rantanen, et al.. (2019). Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort. Cancer Epidemiology. 64. 101631–101631. 6 indexed citations

13.

Erickson, Andrew, Stig Nordling, Markku Kallajoki, et al.. (2018). New prostate cancer grade grouping system predicts survival after radical prostatectomy. Human Pathology. 75. 159–166. 17 indexed citations

14.

Seikkula, Heikki, Pieter Janssen, Manuela Tutolo, et al.. (2017). Comparison of Functional Outcome after Extended versus Super-Extended Pelvic Lymph Node Dissection during Radical Prostatectomy in High-Risk Localized Prostate Cancer. Frontiers in Oncology. 7. 280–280. 9 indexed citations

15.

Yu, Lan, Mervi Toriseva, Andrew Erickson, et al.. (2017). Abstract 5730: Increased FGFRL1 expression is associated with prostate cancer progression. Cancer Research. 77(13_Supplement). 5730–5730. 1 indexed citations

16.

Laajala, Teemu D., Heikki Seikkula, Fatemeh Seyednasrollah, et al.. (2016). Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy. Scientific Reports. 6(1). 36161–36161. 6 indexed citations

17.

Erickson, Andrew, Heikki Seikkula, Johan Lundin, et al.. (2016). Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy. Modern Pathology. 29(12). 1565–1574. 35 indexed citations

18.

Yu, Lan, Mervi Toriseva, Heikki Seikkula, et al.. (2016). Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy. International Journal of Cancer. 139(1). 140–152. 24 indexed citations

19.

Mirtti, Tuomas, et al.. (2015). Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression. PLoS ONE. 10(10). e0140671–e0140671. 29 indexed citations

20.

Seikkula, Heikki, Kari T. Syvänen, Samu Kurki, et al.. (2014). Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 33(1). 16.e1–16.e7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact